Calcitriol 1mcg/1mL Injection

Calcitriol 1mcg/1mL is an injectable form of calcitriol, the active form of vitamin D. Calcitriol helps the body absorb calcium, supports bone mineral balance, and suppresses excess parathyroid hormone. Too much calcitriol can cause hypercalcemia, which may present with nausea, vomiting, constipation, weakness, thirst, frequent urination, confusion, or abnormal heart rhythm. This injection is for healthcare-professional use and should be reviewed alongside calcium supplements, vitamin D products, thiazide diuretics, digoxin, magnesium products, and phosphate binders.
Calcitriol 1mcg/1mL is given intravenously by healthcare staff, often in a renal-care or dialysis setting. Blood calcium, phosphorus, parathyroid hormone, and related medicines should be monitored. Do not add extra calcium or vitamin D unless the clinician advises it.
Calcitriol binds vitamin D receptors, increasing intestinal calcium absorption and helping regulate calcium, phosphorus, and parathyroid hormone balance.
Possible effects are often linked to high calcium and include nausea, vomiting, constipation, weakness, headache, thirst, frequent urination, dry mouth, metallic taste, confusion, or muscle pain. Serious concerns include severe hypercalcemia, high phosphorus, kidney-stone risk, calcification problems, and abnormal heart rhythm.
Monitoring is essential. Tell the care team about high calcium, high vitamin D levels, kidney stones, heart rhythm medicines such as digoxin, calcium supplements, vitamin D products, magnesium antacids, phosphate binders, pregnancy, and breastfeeding.
Secondary hyperparathyroidism and calcium-mineral balance management in chronic kidney disease/dialysis settings when injectable calcitriol is prescribed.
Supports controlled correction of active vitamin D deficiency effects, helps manage parathyroid hormone overactivity, and contributes to bone-mineral balance when labs are monitored.
Calcitriol 1mcg/1mL is used in supervised renal care to help manage calcium-mineral balance and secondary hyperparathyroidism for injectable calcitriol treatment.
Calcitriol can raise calcium and phosphorus, so labs guide dosing and prevent complications.
Only if the clinician advises it. Extra vitamin D can increase hypercalcemia risk.
Nausea, constipation, weakness, thirst, frequent urination, confusion, or irregular heartbeat may suggest high calcium.
Kidney disease reduces active vitamin D regulation, which can worsen calcium balance and parathyroid hormone levels.
Calcitriol, Active vitamin D, Dialysis mineral bone disorder, Secondary hyperparathyroidism, Calcium phosphorus monitoring, Hypercalcemia warning, AR: Calcitriol / حقن, FR: Calcitriol /, PT: Calcitriol / injeção, ES: Calcitriol / inyección, RU: Calcitriol / инъекция, ID: Calcitriol / injeksi, VI: Calcitriol / thuốc tiêm, MS: Calcitriol / suntikan, TL: Calcitriol / iniksyon, ZH-SG: Calcitriol / 注射剂
International B2B Enquiry
Send a structured B2B enquiry for Calcitriol 1mcg/1mL Injection under Bone Health. Global Medicines Export helps international buyers review product information, pack details, quantity requirements, destination-market needs, quotation support and export documentation coordination from India.
Product name, required strength or pack, expected quantity, destination country, buyer type and preferred manufacturer if any.
Availability, quotation support, documentation expectations and shipment-ready order communication can be reviewed before confirmation.
Commercial invoice, packing information, manufacturer details, batch details and supporting documents where applicable and available.
Product availability, quotation, and documentation support are coordinated for international B2B enquiries.
Calcitriol 1mcg/1mL Injection